The expense of equipment and technology can only be justified if the experts using them are available, which is again an important challenge when it comes to Single cell omics market.
North America accounted for the largest share of the cell dissociation market in 2020
Pharmaceutical and Biotechnology industries for the largest share of the cell dissociation market in 2020
In 2021, Roche Diagnostics Signed a definitive merger agreement with GenMark Diagnostics to access novel technologies to test for a broad range of pathogens in one patient sample.
In 2021, Roche Diagnostics Signed a definitive merger agreement with GenMark Diagnostics to access novel technologies to test for a broad range of pathogens in one patient sample.
North America accounted for the largest share of the cell dissociation market in 2020.
North America accounted for the largest share of the cell dissociation market in 2020
GROWTH OPPORTUNITY: Growth opportunities in emerging markets
Pharmaceutical and biotechnology companies are the largest end-users of the cell dissociation market
Enzymatic dissociation products are estimated to account for the largest share of the cell dissociation market
Expansions, Acquisitions, and Agreements were the Most Adopted Growth Strategies by Key Players in the Cell Dissociation Market
The global Cell Dissociation Market is segmented by product, tissue, type, end user, and region.
To track and analyze competitive developments such as agreements; acquisitions; expansions; and R&D activities in the cell dissociation market
North America will continue to dominate the global market in the forecast period.
North America is expected to command the largest share of the market during the forecast period.
North America is expected to command the largest share of the market during the forecast period.
The cell dissociation market is expected to reach USD 440.5 Million by 2023 from USD 241.2 Million in 2018, at a CAGR of 12.8%.
The cell dissociation market is expected to reach USD 440.5 Million by 2023 from USD 241.2 Million in 2018, at a CAGR of 12.8%.